ClinicalTrials.gg
Status unknownNCT02785965Updated Sep 12, 2017

Acupuncture in the Regulation of Dai Meridian for Polycystic Ovarian Syndrome Patients With Abdominal Obesity

An interventional study of electroacupuncture and lifestyle modification in Polycystic Ovarian Syndrome and Obesity, Abdominal, sponsored by Dongfang Hospital Beijing University of Chinese Medicine. Status unknown at 2 sites in China. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2017-09-12.

Sponsored by Dongfang Hospital Beijing University of Chinese Medicine · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Active, not recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 107 studies in Polycystic Ovary Syndrome with a site in China — 29 open to participants now, 33 under way, none of them phase 3. Polycystic Ovary Syndrome · China.

Planned enrollment
55th of 86
84 · median 100
Started
2016
with 8 others
No phase
51 of 107
11 open now
Registered
23rd of 107
by date

Among the 107 studies in Polycystic Ovary Syndrome with a site in China, this one is the 55th largest by planned enrollment of the 86 interventional ones that give a count, is one of 9 that started in 2016, is one of 51 with no phase, and was the 23rd registered.

Polycystic Ovary Syndrome

958 studies on the registry are indexed under Polycystic Ovary Syndrome; 176 are open to participants now.

Browse Polycystic Ovary Syndrome studies →

Open to participants now

29 of the 107 studies in Polycystic Ovary Syndrome with a site in China are open now. Recruiting first, the newest first:

24 more — sign in →

All 29 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 120 Polycystic Ovary Syndrome studies recruiting now, 11 (9%) set no upper age limit and 106 (88%) stop at 75 or younger; 23 take children under 18; 41 take healthy volunteers.

This study: 20 Years to 40 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 107 studies in Polycystic Ovary Syndrome with a site in China, or all of them as a file.
02

Study summary

The purpose of this study is to determine whether the use of electroacupuncture to dredge and regulate Dai Meridian combined with lifestyle modification are more effective than lifestyle modification only in the treatment of anovulation and hyperandrogenism due to polycystic ovary syndrome (PCOS) with abdominal obesity.Two thirds of participants will receive electroacupuncture and lifestyle modification in combination, while the other one third will receive lifestyle modification only.

Read the detailed description

Obesity, especially abdominal obesity, is one of most common clinical features of polycystic ovary syndrome, a widely and seriously influenced complex disorder related to reproduction and metabolism. Excessive accumulation of adipose tissue in the abdominal organs often leads to insulin resistance, which will increase the harm of hyperandrogenism and exacerbate ovulation disorders and metabolic abnormalities.

Weight loss, likely beneficial for both reproductive and metabolic dysfunction in this setting , has been generally recommended as a first-line therapy for obese women with PCOS and can be accomplished via lifestyle modification and electroacupuncture. What's more, stimulating acupoints of Dai Meridian can regulate menstrual cycles and treat infertility according to the theory of traditional Chinese medicine. However, how much benefits patients will additionally get from the Combined therapy is not clear now.

03

Conditions studied

  • Polycystic Ovarian Syndrome
  • Obesity, Abdominal

Keywords

  • electroacupuncture
  • lifestyle modification
  • diet
  • exercise
  • Dai Meridian
04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of Polycystic Ovarian Syndrome.
  • Clinical diagnosis of abdominal obesity.
  • Agree to participate in clinical trials.

Exclusion criteria

Exclusion Criteria:

  • Endocrine or neoplastic causes of amenorrhoea, anovulation and hyperandrogenemia, including central nervous system abnormalities, premature ovarian failure, thyroid disease, Cushing's syndrome,androgen secreting tumors, congenital adrenal hyperplasia, and hyperprolactinaemia.
  • Patients suffering from other serious diseases(cardiocerebrovascular diseases, damage to the function of liver and kidney, and mental illness).
  • Patients taking hormonal and metabolic drugs within 12 weeks of study entry affecting the judgment of results.
  • Pregnant or breast feeding.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
84 participants (estimated)

Study arms

  • Experimental
    acupuncture & lifestyle modification

    Electro-acupuncture is given three times a week with diet restriction to 1400 calories a day and moderate aerobic exercise 3h a week for 12 weeks.

    Device: electroacupuncture · Behavioral: lifestyle modification

  • Active comparator
    lifestyle modification

    diet restriction to 1400 calories a day and moderate aerobic exercise 3h a week for 12 weeks

    Behavioral: lifestyle modification

Interventions

  • Deviceelectroacupuncture

    Disposable, single-use, sterilized stainless-steel needles (Yunlong, Beijing, China; length 40/100 mm, diameter 0.30 mm) are inserted into waist, bilaterally. All of the six points are located in the Dai Meridian route corresponding to the ovaries. Four needles, 0.25mm in diameter and 25mm in length, are also placed in distal acupuncture points which are located in the feet and lower arms to enhance local points' effects. Acupuncture needles of 0.3mm in diameter and 100mm in length are inserted into GB26(Daimai) with a depth of 25-65mm by an angle of 15°, following the path of Dai Meridian (towards medial and downside). The other needles are inserted vertically into the acupoints with a depth of 10-30mm, depending on the thickness of muscles. Electro-acupuncture is applied to both sides of GB26 and ST25(Tianshu): cathode is connected to GB26; anode to ST25. Needles are stimulated electrically with low frequency (2 Hz) for 20 min.

  • Behaviorallifestyle modification

    The diet restricts patients to 1400 calories a day for 12 weeks.The exercise included 12 weeks of aerobic exercise in moderate level (60 to 70% of maximum heart rate), for 3 sessions a week, each session for 60 min. The exercises included: Warning up: 10 min, main phase (aerobic exercise): 40 min and cooling down: 10 min. Polar Pulse measuring device from China was used to control the intensity of the exercises.

06

What researchers measure

Primary outcomes

  1. rate of recovered ovulation

    the proportion of patients who have ovulation after treatment

    Time frame: 12 weeks

Secondary outcomes

  1. evidence of clinically definite hyperandrogenism confirmed by mF-G score

    Time frame: 12 weeks

  2. evidence of clinically definite hyperandrogenism confirmed by the Global Acne Grading System

    Time frame: 12 weeks

  3. frequency of menstruation

    Time frame: 12 weeks

  4. quantity of menstruation

    pictorial blood loss assessment chart

    Time frame: 12 weeks

  5. Serum total testosterone (T)

    Time frame: 12 weeks

  6. FSH

    follicle stimulating hormone (FSH)

    Time frame: 12 weeks

  7. LH

    luteinizing hormone (LH)

    Time frame: 12 weeks

  8. ovarian volume measured by ultrasound

    Time frame: 12 weeks

  9. follicle number pre ovary measured by ultrasound

    Time frame: 12 weeks

  10. ovarian stromal blood flow measured by ultrasound

    Time frame: 12 weeks

  11. body weight in kilograms

    Time frame: 4, 8 and 12 weeks

  12. waist circumference in centimeter

    Time frame: 4, 8 and 12 weeks

  13. BMI in kg/m^2

    Time frame: 4, 8 and 12 weeks

  14. waist-to-height ratio

    waist-to-height ratio=waist circumference in centimeter/height in centimeter

    Time frame: 4, 8 and 12 weeks

  15. Fasting serum PAI-1 level

    Time frame: 12 weeks

  16. International physical activity scale (IPAQ) short version

    Time frame: 4, 8 and 12 weeks

07

Study locations

2 sites
  • Department of Acupuncture and Moxibustion, Dongfang Hospital, Beijing University of Chinese Medicine
    Beijing, Beijing 100078, China
  • Dongfang Hospital Affiliated to Beijing University of Chinese
    Beijing, Beijing 100078, China
08

References and documents

Publications

  • Abazar E, Taghian F, Mardanian F, Forozandeh D. Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome. Adv Biomed Res. 2015 Mar 25;4:68. doi: 10.4103/2277-9175.153892. eCollection 2015. PubMed 25878993 ↗
  • Case problem: dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome. J Am Diet Assoc. 2000 Aug;100(8):955-7; discussion 957-60. doi: 10.1016/S0002-8223(00)00275-3. No abstract available. PubMed 10955058 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2016, a primary completion of Jan 2019 and a completion of Sep 2019. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2016
First posted
May 30, 2016
Start
Jul 2016
Primary completionEst.
Jan 2019
CompletionEst.
Sep 2019
Last update
Sep 12, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 12, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02785965
Lead sponsor
Dongfang Hospital Beijing University of Chinese Medicine
Collaborators
Beijing University of Chinese Medicine, Beijing Municipal Science & Technology Commission
Responsible party
Hui Hu (Director,clinical research, Dongfang Hospital Beijing University of Chinese Medicine) — Principal investigator
First posted
May 30, 2016
Start date
Jul 2016
Primary completion
Jan 2019 (estimated)
Completion
Sep 2019 (estimated)
Last update
Sep 12, 2017

Study contacts

Hui HU, Doctor
principal investigator · Dongfang Hospital Beijing University of Chinese Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion